Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically ...

While mRNA vaccines have received intense attention of late, another class of nucleic acid therapeutics has been growing steadily in recent years. Its impact could be equally profound. Nucleic ...

Our research aims to develop and utilise nucleic acid therapeutics for new and effective therapies targeting disease, but also to improve the efficiency of our manufacturing processes and analytical ...

"Nucleic Acid Therapeutics welcomes this fine addition to the armamentarium of bioanalytical assays needed to identify ...

Carl Ascoli, Chief Science Officer, working with Inês Fial, Research Assistant at the Nucleic Acid Therapeutics Accelerator (NATA, Oxford, United Kingdom), have co-authored a peer-reviewed ...

The Nucleic Acids Institute is dedicated to understanding the chemical and biological basis for nucleic acid function, and to developing new and powerful nucleic acids based therapeutic and ...

They are essential for the survival and reproduction of life on Earth. The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). TComparison of a single-stranded ...

The development and commercialization of nucleic acid-based therapeutics, including messenger RNA (mRNA), plasmid DNA (pDNA) and lipid nanoparticles (LNP) drug products, hold immense promise for ...